Literature DB >> 9008608

Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides.

M J Yellin1, V D'Agati, G Parkinson, A S Han, A Szema, D Baum, D Estes, M Szabolcs, L Chess.   

Abstract

OBJECTIVE: To investigate potential mechanisms by which CD40L-mediated signals may be involved in the pathogenesis of lupus glomerulonephritis (GN).
METHODS: Renal in situ CD40L and CD40 expression was examined in patient biopsy specimens. Immunohistochemical studies were performed on frozen sections utilizing anti-CD40L monoclonal antibody (MAb), anti-CD40 MAb, or control MAb. As controls, we analyzed normal kidney specimens and specimens obtained from patients with IgA nephropathy, focal segmental glomerulosclerosis, minimal change disease, idiopathic membranous GN, and antineutrophil cytoplasmic antibody-positive pauci-immune GN. Staining distribution was noted and staining intensity scored on a semiquantitative scale of 0 (no staining) to 3+ (intense staining).
RESULTS: In normal kidney, CD40 was expressed on parietal epithelial cells, mesangial cells, endothelial cells, and distal tubules but not proximal tubules. Glomerular and tubular CD40 expression was markedly up-regulated in class III and class IV lupus GN, where there was intense staining of crescents, proximal and distal tubules, and interstitial mononuclear cells. In contrast, CD40 expression in class V lupus GN was similar to that in normal kidney. Interstitial mononuclear cells expressing CD40L were present in class IV lupus GN. However, these findings were not unique to lupus GN: up-regulation of CD40 and CD40L expression was similarly observed in other inflammatory renal diseases.
CONCLUSION: This study shows that CD40 is expressed on a variety of renal parenchymal and non-parenchymal cells in normal kidney. Renal CD40 expression is up-regulated in class III and class IV lupus nephritis, as well as in other inflammatory renal diseases, and is associated with the presence of CD40L+ mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008608     DOI: 10.1002/art.1780400117

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

Review 1.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

Authors:  Jay Mehta; Anna Genin; Michael Brunner; Lisabeth V Scalzi; Nilamadhab Mishra; Timothy Beukelman; Randy Q Cron
Journal:  Arthritis Rheum       Date:  2010-08

3.  Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival.

Authors:  Robin Lesley; Lisa M Kelly; Ying Xu; Jason G Cyster
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

4.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

5.  CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

Authors:  Jonathan M Weiss; W Gregory Alvord; Octavio A Quiñones; Jimmy K Stauffer; Robert H Wiltrout
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

Review 6.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 7.  Epithelial cells as immune effector cells: the role of CD40.

Authors:  Kari Dugger; Thomas W Lowder; Torry A Tucker; Lisa M Schwiebert
Journal:  Semin Immunol       Date:  2009-07-22       Impact factor: 11.130

8.  Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.

Authors:  Karin S Peterson; Jing-Feng Huang; Jessica Zhu; Vivette D'Agati; Xuejun Liu; Nancy Miller; Mark G Erlander; Michael R Jackson; Robert J Winchester
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 9.  CD154 transcriptional regulation in primary human CD4 T cells.

Authors:  Randy Q Cron
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.